Navigation Links
Convergence Pharmaceuticals Announces Successful Interim Data from Ground-Breaking Phase II Trigeminal Neuralgia Study
Date:3/27/2013

CAMBRIDGE, England, March 27, 2013 /PRNewswire/ --

Novel sodium channel blocker with excellent pharmacokinetic and safety profile could fill treatment gap for severe pain condition

Convergence Pharmaceuticals Limited ("Convergence"), the company focused on the development of novel analgesic medicines for the treatment of chronic pain, today announces positive interim data from the ongoing Phase II clinical trial of novel sodium channel blocker CNV1014802 in patients with trigeminal neuralgia (TN), a very severe form of facial pain.

CNV1014802 is a novel small molecule state-dependent sodium channel blocker that exhibits potency and selectivity against the Nav 1.7 sodium channel. The Phase II study utilises a novel design, whereby eligible patients are entered into a 3-week open-label treatment period with CNV1014802 at a dose of 150mg three times a day (tid). If a successful response is observed in the final week of this period, patients are then randomised to a 4-week double-blind treatment period with either CNV1014802 150mg tid or placebo.

A planned interim analysis was performed once a pre-defined number of patients had completed the 3-week open-label treatment period. Success criteria for individual patient response was defined as a 30% or more reduction in numbers of paroxysms, or severity of paroxysms, relative to the run-in period. A total of 70% patients showed a successful response and were subsequently randomised into the double-blind treatment period. CNV1014802 was well tolerated in these patients. A Data Monitoring Committee (including medical experts in the treatment of trigeminal neuralgia) reviewed all available efficacy and safety data from the open-label treatment period and agreed that the study should continue to completion as defined in the protocol, using the dose regimen of 150mg tid for CNV1014802.

TN is a very severe form of facial pain that is experienced in short bursts or at
'/>"/>

SOURCE Convergence Pharmaceuticals Ltd
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Eighth Annual WLSA Convergence Summit Focuses on Moving from Innovation to Adoption
2. Pharmaceuticals - Scandinavia Industry Guide
3. RoundTable Healthcare Partners and Argon Medical Devices to Acquire Angiotech Pharmaceuticals Interventional Products Business
4. First Patients Dosed in Proof-of-Concept Clinical Study of Alder Biopharmaceuticals Lead Therapeutic Candidate for Treatment of Migraine, ALD403
5. Valeant Pharmaceuticals International, Inc. Agrees to Acquire Obagi Medical Products, Inc. for $19.75 Per Share in Cash
6. Tech Coast Angels Contributes More Than $3 Million to $16 Million Savara Pharmaceuticals Series B
7. Harwood Feffer LLP Announces Investigation of Spectrum Pharmaceuticals, Inc.
8. Star Scientific and Rock Creek Pharmaceuticals Report on the Beneficial Nutritional Effects of Anatabine in an Animal Model of Ulcerative Colitis
9. Inovio Pharmaceuticals Reports 2012 Fourth Quarter and Year End Financial Results
10. Cadence Pharmaceuticals Appoints Stephen L. Newman, M.D., to its Board of Directors
11. Isis Pharmaceuticals to Host Investor Event to Discuss ISIS-SMN Rx Data Presented at 2013 AAN Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... -- You,re visiting the dentist for what you think ... she says you need a root canal. Though it,s ... several questions and feel apprehensive about your upcoming procedure. ... to worry about. The Pennsylvania Dental Association (PDA) wants ... the public may have surrounding this common procedure that ...
(Date:12/19/2014)... HILL, N.C. , Dec. 19, 2014 /PRNewswire/ ... to optimize a product,s web presence to reflect ... Brand websites, in particular, must meet the needs ... regulations and culture. According to ... more than half of the participating companies averaged ...
(Date:12/19/2014)... , December 18, 2014 ... application/module that is used to store, manipulate, and ... comprises a patient tracking and scheduling system, result ... of RIS with HIS and other databases improves ... registration and patient scheduling, patient list management, radiology ...
Breaking Medicine Technology:Root Canals Have Become More Routine 2Building a Best-in-Class Pharma Global Brand Website 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 3
... Pa.--(BUSINESS WIRE)--Apr 19, 2007 - Othera Pharmaceuticals,Inc. ... of,Pharmacology and Executive Vice President and Chairman ... of Pharmacy,will present new preclinical data detailing ... OT-551, and,related Othera compounds. This work stems ...
... --,CuraGen Corporation and TopoTarget A/S announced today ... a histone deacetylase (HDAC) inhibitor being investigated,for ... be presented at two,upcoming major medical meetings. ... discussing interim clinical,results with belinostat will be ...
Cached Medicine Technology:Othera Pharmaceuticals Announces Upcoming Presentation Based Upon,Expanded Understanding of Lead Compound Mechanism of Action 2Othera Pharmaceuticals Announces Upcoming Presentation Based Upon,Expanded Understanding of Lead Compound Mechanism of Action 3Othera Pharmaceuticals Announces Upcoming Presentation Based Upon,Expanded Understanding of Lead Compound Mechanism of Action 4CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 2CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 3CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 4CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 5
(Date:12/22/2014)... December 22, 2014 The Bob ... ever, having invested more than $5 million in ... veterans and their families. , This includes $1.3 ... dozen nonprofits, helping with: veteran entrepreneurship; community impact; ... life-coaches for severely injured veterans. , “The needs ...
(Date:12/22/2014)... Give a loved one the greatest gift ... and vitality. , For a limited time, HealthiPlus ( ... in special Holiday Wellness gift packages at drastically reduced ... bottle contains cutting-edge, proven nutritional support for joints, mental ... as we age. , Joint Health Plus ...
(Date:12/22/2014)... 22, 2014 Xarelto Lawsuit News ... of judges has granted a request to centralize pending ... District Court, Eastern District of Louisiana. The U.S. Judicial ... December 12 to transfer over 50 Xarelto cases–21 lawsuits ... the Louisiana court for consolidation under U.S. District Judge ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 Christmas is days ... has a fast and easy solution that will please: the ... can be purchased from from $25 up to $350," says ... 100% customer satisfaction and a wide array of skin care ... fees and no expiration dates. , Gift delivery past ...
(Date:12/22/2014)... The NLN’s 2015 Leadership Institute ... month. Faculty have been selected through competitive application ... for administrative leadership roles within their academic institutions; ... Educators, featuring a curriculum uniquely devised for up-and-comers ... , Twenty nurse educators were chosen for the ...
Breaking Medicine News(10 mins):Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 2Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 3Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 4Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 5Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 6Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 7Health News:You Still Have Time to Give the Gift of Health and Vitality to a Mature Loved One 2Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 2Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 3Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 4Health News:NLN Leadership Institute Announces 2015 Cohorts 2Health News:NLN Leadership Institute Announces 2015 Cohorts 3
... Blue Cross Blue Shield of Michigan has,been named 2007 ... Michigan,Minority Business Development Council., The award recognizes the ... of suppliers to the corporation., "Blue Cross Blue ... because it recognizes our strong commitments to diversity and ...
... infants make distinctions based on behaviors , , WEDNESDAY, Nov. 21 (HealthDay ... learned language can still judge who is friend and who is ... who cooperate versus people who hurt, and this ability could be ... the Yale researchers. Their study is published in the Nov. 22 ...
... Susan G. Komen for the Cure, the,nation,s ... research and,community-based outreach programs, is accepting applications to ... a,parent to breast cancer., (Logo: http://www.newscom.com/cgi-bin/prnh/20070122/NYM084LOGO ... students cover the costs of,tuition, books, fees and ...
... (Amex: IMA ), announced today that it closed ... a total,of 13,634,302 shares in the offering at a ... of shares sold by the Company included,1,800,000 shares sold ... in full. Certain selling stockholders of the Company,also sold ...
... widespread and often deadly among older American women, doctors ... to a new report by a team of vascular ... Cornell Medical College campuses of NewYork-Presbyterian Hospital. , Much ... years, cardiovascular research has focused almost exclusively on males, ...
... CITY, Calif., Nov. 21 Genomic Health,Inc. (Nasdaq: ... Ph.D., Genomic,Health,s Chairman and Chief Executive Officer, will ... New York, NY on November 28, 2007 at ... and subsequently archived webcast of the,presentation, visit the ...
Cached Medicine News:Health News:Blue Cross Blue Shield of Michigan Named 2007 Corporation of the Year in Health Care by Michigan Minority Business Development Council 2Health News:Babies Can Tell Friend From Foe 2Health News:Susan G. Komen for the Cure Provides Scholarships for Students Who Lost a Parent to Breast Cancer 2Health News:Inverness Medical Innovations Announces Closing of Public Offering 2Health News:Arterial vascular disease underdiagnosed, undertreated in older US women 2Health News:Arterial vascular disease underdiagnosed, undertreated in older US women 3Health News:Arterial vascular disease underdiagnosed, undertreated in older US women 4Health News:Genomic Health to Present at 19th Annual Piper Jaffray Health Care Conference 2
... Care Xpress is an innovative, stat analyzer ... hematology with on-board co-oximetry and integrated data ... Measured tests include pH, PCO 2 , ... and hemoglobin, sodium, potassium, chloride, ionized calcium, ...
... Kohden developed the world's first ... was completely AC powered in ... developed a number of standard ... measuring systems, such as a ...
... in Digital EEG ,The company that ... presents the latest addition to the ... This innovative system incorporates the latest ... information management to offer you unprecedented ...
Optoelectronic stimulator, "ganzfeld" stimulations for flash VEP, flash ERG and sensory EOG. Pattern stimulations for ERG and VEP, multifocal stimulations for ERG and VEP, complies with international...
Medicine Products: